Jim Dobbin MP reselected for 2015 election

http://www.rochdaleonline.co.uk/news-features/2/news-headlines/88650/jim-dobbin-to-be-labour-candidate-for-heywood-and-middleton-constituency-at-general-election

Posted in Uncategorized | Leave a comment

Response from Jane Ellison MP, Public Health Minister, 10 July 2014 to a letter from Jim Dobbin MP, 4 April 2014

Click here to read Page 1

Click here to read Page 2

Posted in Uncategorized | Leave a comment

Benzodiazepine litigation Official Transcripts 1990 – 1997

Click here to read transcripts

Posted in Uncategorized | Leave a comment

Wayne Douglas benzo campaign in Japan

Click here to visit Benzo Case Japan website

Posted in Uncategorized | Leave a comment

Article in The Bulletin, Oregon US

Click here to read article

Posted in Uncategorized | Leave a comment

Parliamentary Questions by Jim Dobbin MP

Drinking Water: Contamination

Jim Dobbin: To ask the Secretary of State for Environment, Food and Rural Affairs with reference to the answer 196584 of 6 May 2014, Official Report, column 41W, on drinking water, what plans his Department has to test for the levels of tranquillisers and antidepressants in drinking water; and if his Department will conduct a study into levels of psychotropic drugs in UK river and seawater. [201036]

Dan Rogerson: In 2012, the Drinking Water Inspectorate (DWI) published research looking at pharmaceuticals likely to present the worst case scenario in drinking water. Fluoxetine was included in the study, the outcome of which was that these pharmaceuticals presented no concern for public health. The research is part of an ongoing risk assessment which is revisited in the event of new information. The DWI has also responded to the earlier PQ (0019) on this matter.

23 Jun 2014 : Column 64W

Monitoring river water and seawater is driven by requirements under the EU water framework directive (WFD). As psychotropic drugs have not been identified as harmful chemicals under the WFD they are not routinely monitored, although they may be detected in less specific investigations.

The water industry has undertaken collaborative research into chemicals in sewage effluent through the UK Water Industry Research (UKWIR) Chemicals Investigation Programme. Some medicines were included in the first programme of 2010-13, including fluoxetine. A second Chemical Investigations Programme, beginning in 2015, will look at the psychoactive medicines fluoxetine and sertraline in sewage effluent.

23 Jun 2014 : Column 13W

Antidepressants

Jim Dobbin: To ask the Secretary of State for Health with reference to the answer of 19 January 2012, Official Report,columns 932-3W, how many companies hold licences for the manufacture or distribution of (a) Nitrazepam, (b) Flurazepam, (c)Loprazolam, (d) Lormetazepam, (e) Temazepam, (f) Clonazepam, (g) Medazepam, (h) Midazolam, (i) Zopiclone, (j) Zaleplon,(k) Zolpiden, (l) Eszopiclone, (m) SSRI antidepressants and (n) trycyclic antidepressants; and how many of those licences were issued in the last three years. [201050]

Norman Lamb: There are currently 15 products authorised in the United Kingdom containing nitrazepam and 15 different companies authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing flurazepam and one company authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing loprazolam and two different companies authorised to manufacture and distribute them.

There are currently eight products authorised in the UK containing lormetazepam and four different companies authorised to manufacture and distribute them.

There are currently 10 products authorised in the UK containing temazepam and six different companies authorised to manufacture and distribute them.

There are currently six products authorised in the UK containing clonazepam and three different companies authorised to manufacture and distribute them.

There are currently no authorised products in the UK containing medazepam.

There are currently 22 products authorised in the UK containing midazolam and 10 different companies authorised to manufacture and distribute them.

There are currently 17 products authorised in the UK containing zopiclone and nine different companies authorised to manufacture and distribute them.

There are currently two products authorised in the UK containing zaleplon and one company authorised to manufacture and distribute them.

There are currently 21 products authorised in the UK containing zolpidem and 12 different companies authorised to manufacture and distribute them.

There are currently no authorised products in the UK containing eszopiclone.

There are currently 238 products authorised in the UK containing SSRI antidepressants and 57 different companies authorised to manufacture and distribute them.

There are currently 16 products authorised in the UK containing tricyclic antidepressants and 11 different companies authorised to manufacture and distribute them.

One loprazolam, four lormetazepam, two clonazepam, two midazolam, three zopiclone, four zolpidem and 75 SSRI products have been authorised in the last three years.

Posted in Uncategorized | Leave a comment

Meeting with Duncan Selbie, CEO, PHE promised by Jane Ellison, Public Health Minister has not happened

5 July 2014

Dear Jane Ellison,

I am informed by an email today from Alex Sienkiewicz, Chief of Staff, PHE, that no meeting has taken place between you and Duncan Selbie, CEO, PHE on the issue of involuntary tranquilliser addiction. Alex Sienkiewicz says ” there is not a note of conversations between PHE’s Chief Executive and the Minister for Public Health, who has not yet raised this matter with Mr Selbie”.

Would you please explain the delay on such an important issue which you made special mention of in handwriting at the end of your letter of 17 January 2014 attached.

Would you confirm when a meeting is planned on this issue and also when you intend to answer Jim Dobbin MP’s letter to you of 4 April 2014?

Yours sincerely,

John Perrott

Posted in Uncategorized | Leave a comment

GPs forced to prescribe as psychological therapies services are ‘bursting at seams’

Click here to read article in Pulse

Posted in Uncategorized | Leave a comment

email to Duncan Selbie, Chief Exec, PHE, 20 June 2014

Dear Duncan Selbie,

The FOI response (attached) shows that there were no agenda or minutes relating to a meeting between you and Jane Ellison MP, Public Health Minister, on the issue of involuntary tranquilliser addiction and to which Jane Ellison makes a special point of referring in handwriting at the end of her letter (attached).

Would you please confirm whether any such meeting took place, what was discussed and what action is planned on this issue?

Yours sincerely,

John Perrott

Posted in Uncategorized | Leave a comment

Daily Mail apologises to Baylissa Frederick

http://www.dailymail.co.uk/news/article-2633969/Clarifications-corrections.html

http://www.smab.co.uk/news/news/daily-mail-apologies-to-health-campaigner-baylissa-frederick-.aspx

Posted in Uncategorized | Comments Off